Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression

Jay A. Brieler, Patrick J. Lustman, Jeffrey F. Scherrer, Joanne Salas, F. David Schneider

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Objective. Depression is prevalent in diabetes and is associated with increased risks of hyperglycaemia, morbidity and mortality. The effect of antidepressant medication (ADM) on glycaemic control is uncertain owing to a paucity of relevant data. We sought to determine whether the use of ADM is associated with glycaemic control in depressed patients with type 2 diabetes. Research design and methods. A retrospective cohort study (n = 1399) was conducted using electronic medical record registry data of ambulatory primary care visits from 2008 to 2013. Depression and type 2 diabetes were identified from ICD-9-CM codes; ADM use was determined from prescription orders; and glycaemic control was determined from measures of glycated haemoglobin (A1c). Good glycaemic control was defined as A1c < 7.0% (53 mmol/mol). Generalized estimating equations were used to determine the effect of depression and ADM use on glycaemic control. Results. Good glycaemic control was achieved by 50.9% of depressed subjects receiving ADM versus 34.6% of depressed subjects without ADM. After adjusting for covariates, depressed patients receiving ADM were twice as likely as those not receiving ADM to achieve good glycaemic control (odds ratio = 1.95; 95% confidence interval: 1.02-3.71). Conclusions. In this retrospective cohort study of a large sample of primary care patients with type 2 diabetes, ADM use was associated with improved glycaemic control.

Original languageEnglish
Pages (from-to)30-36
Number of pages7
JournalFamily Practice
Issue number1
StatePublished - Feb 1 2016


  • Antidepressive agents
  • Anxiety
  • Depression
  • Diabetes mellitus type 2
  • Medical records
  • Primary health care


Dive into the research topics of 'Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression'. Together they form a unique fingerprint.

Cite this